Maintenance Metronomic Per OS Navelbine In Advanced NSCLC Patients After Previous Platinum Based Chemotherapy: A Multicenter Randomized Best Supportive Care Controlled Phase II Study - MA.NI.LA. Trial

Trial Profile

Maintenance Metronomic Per OS Navelbine In Advanced NSCLC Patients After Previous Platinum Based Chemotherapy: A Multicenter Randomized Best Supportive Care Controlled Phase II Study - MA.NI.LA. Trial

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 29 May 2017

At a glance

  • Drugs Vinorelbine (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms MA-NI-LA; MANILA; ONC-MANILA12
  • Most Recent Events

    • 23 May 2017 Status changed from recruiting to active, no longer recruiting.
    • 17 May 2016 Planned End Date changed from 1 Dec 2016 to 1 Oct 2018.
    • 17 May 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top